Business Context and Reporting Period
Company: Assured Guaranty Ltd. (AGO)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended June 30, 2025
Business Overview: A Bermuda-based holding company providing financial guaranty insurance for U.S. and non-U.S. public finance and structured finance markets, alongside asset management activities through its interest in Sound Point Capital Management.
Key Financial Metrics
| Metric (in millions) | Q2 2025 | Q2 2024 | 6M 2025 | 6M 2024 |
|---|---|---|---|---|
| Total Revenues | $281 | $202 | $626 | $447 |
| Net Income Attributable to AGL | $103 | $78 | $279 | $187 |
| Diluted EPS | $2.08 | $1.41 | $5.54 | $3.31 |
| Adjusted Operating Income (Non-GAAP) | $50 | $80 | $212 | $193 |
| Net Investment Income | $89 | $81 | $176 | $165 |
| Loss and LAE Expense | $28 | $(2) Benefit | $68 | $(3) Benefit |
| Total Assets | $12,095 | N/A | N/A | N/A |
| Shareholders' Equity (Attributable to AGL) | $5,633 | N/A | N/A | N/A |
| Long-Term Debt | $1,701 | N/A | N/A | N/A |
| Cash and Cash Equivalents | $301 | N/A | N/A | N/A |
Note: Balance sheet data is as of June 30, 2025, compared to December 31, 2024 ($11,901M Total Assets; $5,495M Equity; $1,699M Debt; $121M Cash).
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 39% in Q2 2025 and 40% in the six months ended June 30, 2025, compared to the prior year periods.
- Foreign Exchange Impact: A significant driver of the increase was a foreign exchange gain on remeasurement of $79 million in Q2 2025 and $116 million for the six months, compared to no gain in Q2 2024 and a $12 million loss in the prior six months.
- LBIE Litigation Resolution: The Company recognized a realized gain of $103 million in the first quarter of 2025 (included in six-month results) related to the full satisfaction of the judgment against Lehman Brothers International (Europe) (LBIE).
- Loss Expense: Loss and LAE expense increased to $28 million in Q2 2025 from a $2 million benefit in Q2 2024, driven by higher expected losses in U.S. and non-U.S. public finance sectors (specifically healthcare and U.K. regulated utilities).
- Investment Income: Net investment income rose due to income from CLO equity tranches reclassified to the available-for-sale portfolio in late 2024.
Guidance, Outlook, and Risks
Management Commentary and Outlook
- Capital Management: The Board authorized an additional $300 million share repurchase program on August 6, 2025. As of that date, approximately $356 million remained authorized. The Company repurchased 1.54 million shares in Q2 2025.
- Dividends: AG Re declared a $50 million dividend in Q2 2025. AG expects to pay quarterly dividends of $71.8 million in 2025 following regulatory non-objection.
- Business Strategy: Continued focus on loss mitigation, particularly for Puerto Rico (PREPA) and U.K. regulated utility exposures. The Company is actively engaged in restructuring negotiations for Thames Water Utilities Finance PLC.
Risks and Contingencies
- Puerto Rico (PREPA): The Company has $532 million in net par outstanding for PREPA, which remains in default. Litigation regarding the FOMB PREPA Plan and bondholder liens is ongoing, with mediation extended through October 31, 2025.
- U.K. Regulated Utilities: Significant exposure to U.K. water utilities (e.g., Thames Water) facing operational strain and potential restructuring. The Company insures $2.4 billion of net par in Thames Water senior Class A debt.
- Healthcare Sector: Rising labor costs and inflation are creating liquidity stress in certain U.S. healthcare exposures.
- Market Risks: Volatility in credit spreads, interest rates, and foreign exchange rates (particularly GBP and EUR) impacts fair value measurements and remeasurement gains/losses.
Investor Verification Checklist
- Verify LBIE Gain: Confirm the $103 million gain from the LBIE litigation resolution is fully realized and included in the six-month results.
- Assess FX Sensitivity: Evaluate the impact of the $79 million Q2 foreign exchange gain on the sustainability of earnings, given the volatility of the pound sterling and euro.
- Review Loss Reserves: Scrutinize the increase in expected loss to be paid for U.S. healthcare and U.K. utility exposures, which drove the shift from a loss benefit to a $28 million expense in Q2.
- Monitor PREPA Litigation: Track the status of the FOMB PREPA Plan confirmation and the administrative expense claim litigation, which could impact future recoveries on the $532 million exposure.
- Check Share Repurchases: Verify the execution of the new $300 million repurchase authorization and the impact on diluted share count and EPS.